M

Merge Labs

Develops high-bandwidth brain–computer interfaces

Scientist – Non-Viral Gene Delivery

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeSan Francisco, CA, USA$120k - $215k /yrIn-person

About the Job

Requirements

  • A Ph.D. or equivalent experience leading research projects end-to-end in bioengineering, chemical engineering, drug delivery, neuroscience, molecular biology, or a related field.
  • Prior hands-on experience with non-viral delivery vehicles, including lipid nanoparticles or polymeric nanoparticles.
  • Demonstrated expertise in developing, optimizing, or critically evaluating gene delivery modalities.
  • Designed and executed in vivo studies and interpreted delivery and expression results.
  • Experience advancing a delivery technology through preclinical translation or into the clinic.

Responsibilities

  • Identify the best non-viral delivery technologies and help secure access through collaborations, material transfer agreements, or in-licensing.
  • Work hands-on in the lab to formulate, adapt, and characterize lipid nanoparticles, polymeric nanoparticles, and other non-viral vehicles for delivery of nucleic acid payloads to the central nervous system.
  • Define success criteria spanning efficacy and tolerability, and develop the assays and readouts needed to measure them.
  • Design, run, and interpret in vivo studies in rodents and, where appropriate, large animal models, comparing candidate technologies head to head.
  • Evaluate approaches that pair non-viral technologies with ultrasound-mediated blood-brain barrier opening.
  • Assess durability of expression and potential for repeat dosing, and weigh manufacturability and cost of goods alongside performance.
  • Collaborate with molecular engineering and neurobiology colleagues on payload design and expression requirements.
  • Operate independently and drive projects to a result, recruiting and mentoring research associates over time as efforts expand.

Desired Qualifications

  • Experience sourcing, evaluating, or in-licensing delivery technologies through external collaborators.
  • Familiarity with chemistry, manufacturing, and controls, scale-up, or good manufacturing practice considerations for nanoparticle formulations.
  • Familiarity with design considerations for repeat dosing and immunogenicity.
  • Hands-on experience with microfluidic formulation and analytical characterization methods.
  • Experience with ligand or antibody conjugation for targeted nanoparticles.
  • Experience pairing delivery vehicles with focused ultrasound blood-brain barrier opening.
  • Experience working with large animal models.

About the Company

Merge Labs

Develops high-bandwidth brain–computer interfaces

Merge Labs develops brain–computer interfaces to connect human brains with computers. Its product focus is high-bandwidth neural implants that read neural signals and transmit data to AI systems and software, enabling bidirectional communication between brain and machine. The implants are designed to work with advances in AI and neural sensing hardware, using a system of implants, interfaces, and software to interpret brain activity and control devices or software. Compared with competitors, Merge Labs aligns with Sam Altman’s vision of human–machine convergence, leveraging OpenAI ventures connections and positioning itself as a Neuralink rival with an emphasis on higher data throughput and scalable AI-assisted interpretation. The company’s goal is to create seamless, high-bandwidth brain–computer communication that enhances human capabilities and enables new ways of interacting with technology.

Company size
51-200
Company stage
Seed
Total funding
$252M
Headquarters
San Francisco, CA
Founded
2025

Recently Posted Jobs

Explore more opportunities at Merge Labs

See more jobs